JAGSNPHARM.NSE logo

JAGSNPHARM.NSE
Jagsonpal Pharmaceuticals Ltd.

52
Loading...
Loading...
News
all
press releases
News Placeholder
Jagsonpal Pharma’s Rally Faces Litmus Test At ₹320; SEBI RA Vijay Gupta Cautions Supply Zone May Stall Momentum
On the downside, immediate support lies in the ₹250 - ₹260 range, which has previously acted as a breakout base. The analyst recommends re-entry at this point.
Stocktwits·2mo ago
News Placeholder
Momentum Trade Ideas: SEBI RAs See Breakout Opportunities In These Pharma And Industrial Stocks
Analysts have highlighted Jagsonpal, Alkem, Senores Pharma, and Cummins India as strong near-term opportunities based on technical setups and volume action.
Stocktwits·2mo ago
News Placeholder
7 Indian stocks that align with Peter Lynch's growth investing strategy
Seven Indian stocks—Jagsonpal Pharmaceuticals, Sandur Manganese & Iron Ore, G M Breweries, Indian Metal & Ferro Alloys, VST Industries, Maithan Alloys, and D-Link—align with Peter Lynch's growth investing strategy, highlighting their operating revenues, annual revenue growth, profitability margins, and strong balance sheets. These stocks are identified by MarketSmith based on Lynch’s methodology.
cityfalcon.com·7mo ago

Latest JAGSNPHARM.NSE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.